Two Sigma Advisers’s Endava DAVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-12,900
Closed -$740K 2530
2023
Q3
$740K Sell
12,900
-95,300
-88% -$4.97M ﹤0.01% 1649
2023
Q2
$5.6M Buy
108,200
+70,300
+185% +$3.78M 0.01% 716
2023
Q1
$2.55M Sell
37,900
-19,400
-34% -$1.52M 0.01% 1156
2022
Q4
$4.38M Buy
57,300
+39,900
+229% +$2.97M 0.01% 838
2022
Q3
$1.4M Sell
17,400
-20,000
-53% -$1.9M ﹤0.01% 1360
2022
Q2
$3.3M Sell
37,400
-16,700
-31% -$1.75M 0.01% 955
2022
Q1
$7.2M Sell
54,100
-44,300
-45% -$5.58M 0.02% 650
2021
Q4
$16.5M Sell
98,400
-1,500
-2% -$232K 0.04% 351
2021
Q3
$13.6M Sell
99,900
-9,400
-9% -$1.21M 0.04% 432
2021
Q2
$12.4M Buy
109,300
+44,200
+68% +$4.27M 0.03% 485
2021
Q1
$5.51M Buy
65,100
+11,600
+22% +$969K 0.02% 816
2020
Q4
$4.11M Buy
53,500
+15,600
+41% +$1.05M 0.01% 910
2020
Q3
$2.39M Sell
37,900
-7,900
-17% -$428K 0.01% 1073
2020
Q2
$2.21M Sell
45,800
-3,500
-7% -$156K 0.01% 1155
2020
Q1
$1.73M Buy
49,300
+26,200
+113% +$1.19M 0.01% 1191
2019
Q4
$1.08M Buy
23,100
+7,300
+46% +$315K ﹤0.01% 1540
2019
Q3
$598K Hold
15,800
﹤0.01% 1646
2019
Q2
$636K Buy
15,800
+6,000
+61% +$203K ﹤0.01% 1713
2019
Q1
$270K Buy
+9,800
New +$247K ﹤0.01% 2019

Other funds holding DAVA

Two Sigma Advisers's DAVA Position: Q4 2023 in Review

Two Sigma Advisers sold out of Endava (DAVA) in Q4 2023, closing a stake of 12,900 shares — an estimated $740K sold.

Two Sigma Advisers first reported a position in DAVA in Q1 2019 and held it in 19 quarters. The position peaked at $16.5M in Q4 2021. 194 funds tracked by Wall St. Rank hold DAVA as of Q4 2023.

  • Two Sigma Advisers reported no remaining Endava position as of Q4 2023 after selling out during the quarter.
  • Two Sigma Advisers sold 12,900 Endava shares in Q4 2023, an estimated $740K.
  • Two Sigma Advisers first reported a position in Endava in Q1 2019 and held it in 19 quarters.
  • Two Sigma Advisers's Endava position peaked at $16.5M in Q4 2021.
  • 194 funds tracked by Wall St. Rank held Endava as of Q4 2023.

Based on Two Sigma Advisers's 13F filing for Q4 2023, filed 14 Feb 2024.